Kiniksa Pharmaceuticals, Ltd. Banner Image

Kiniksa Pharmaceuticals, Ltd. has reached its limit for free report views

Work for Kiniksa Pharmaceuticals, Ltd.? Upgrade Your Profile and unlock all your annual reports.

Kiniksa Pharmaceuticals, Ltd.

  • Ticker KNSA
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Kiniksa Pharmaceuticals, Ltd. Logo Image
  • 51-200 Employees
  • Based in Lexington, Massachusetts
Kiniksa is a biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need. Kiniksa’s clinical-stage product candidates, rilonacept, mavrilimumab, vixarelimab and KPL-404, are based on strong biologic rationale or validated mechanisms, target underservedMore conditions and offer the potential for differentiation. These pipeline assets are designed to modulate immunological pathways that are implicated across a spectrum of diseases.
Kiniksa Pharmaceuticals, Ltd.

Most Recent Annual Report

Kiniksa Pharmaceuticals, Ltd.
MOST RECENT 2021 Annual Report and Form 10K

Report Locked. Kiniksa Pharmaceuticals, Ltd. has reached its limit for free report views.

Older/Archived Annual Reports